Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of ARS 221.84 trillion. The enterprise value is 298.53 trillion.

Market Cap	221.84T
Enterprise Value	298.53T

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Jan 23, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.23%
Shares Change (QoQ)	-0.49%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	66.53%
Float	5.68B

Valuation Ratios

The trailing PE ratio is 19.67 and the forward PE ratio is 9.29.

PE Ratio	19.67
Forward PE	9.29
PS Ratio	2.44
PB Ratio	1.76
P/TBV Ratio	n/a
P/FCF Ratio	16.84
P/OCF Ratio	13.06
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.94, with an EV/FCF ratio of 22.67.

EV / Earnings	26.47
EV / Sales	3.38
EV / EBITDA	7.94
EV / EBIT	11.04
EV / FCF	22.67

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.78.

Current Ratio	1.16
Quick Ratio	0.80
Debt / Equity	0.78
Debt / EBITDA	2.54
Debt / FCF	7.45
Interest Coverage	7.17

Financial Efficiency

Return on equity (ROE) is 8.89% and return on invested capital (ROIC) is 13.65%.

Return on Equity (ROE)	8.89%
Return on Assets (ROA)	5.68%
Return on Invested Capital (ROIC)	13.65%
Return on Capital Employed (ROCE)	11.20%
Weighted Average Cost of Capital (WACC)	5.58%
Revenue Per Employee	1.21B
Profits Per Employee	150.38M
Employee Count	81,000
Asset Turnover	0.30
Inventory Turnover	1.41

Taxes

Income Tax	-386.07B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +25.31% in the last 52 weeks. The beta is 0.44, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	+25.31%
50-Day Moving Average	9,811.30
200-Day Moving Average	8,757.65
Relative Strength Index (RSI)	55.13
Average Volume (20 Days)	30,701

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.06

Income Statement

In the last 12 months, Pfizer had revenue of ARS 90.83 trillion and earned 11.28 trillion in profits. Earnings per share was 1,980.25.

Revenue	90.83T
Gross Profit	68.85T
Operating Income	27.81T
Pretax Income	10.92T
Net Income	11.28T
EBITDA	37.33T
EBIT	27.81T
Earnings Per Share (EPS)	1,980.25

Full Income Statement

Balance Sheet

The company has 19.73 trillion in cash and 98.18 trillion in debt, giving a net cash position of -78,449.62 billion.

Cash & Cash Equivalents	19.73T
Total Debt	98.18T
Net Cash	-78,449.62B
Net Cash Per Share	n/a
Equity (Book Value)	125.95T
Book Value Per Share	22,073.74
Working Capital	8.58T

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 16.99 trillion and capital expenditures -3,815.73 billion, giving a free cash flow of 13.17 trillion.

Operating Cash Flow	16.99T
Capital Expenditures	-3,815.73B
Free Cash Flow	13.17T
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 75.81%, with operating and profit margins of 30.62% and 12.42%.

Gross Margin	75.81%
Operating Margin	30.62%
Pretax Margin	12.02%
Profit Margin	12.42%
EBITDA Margin	41.10%
EBIT Margin	30.62%
FCF Margin	14.50%

Dividends & Yields

This stock pays an annual dividend of 421.12, which amounts to a dividend yield of 4.19%.

Dividend Per Share	421.12
Dividend Yield	4.19%
Dividend Growth (YoY)	59.39%
Years of Dividend Growth	4
Payout Ratio	125.74%
Buyback Yield	-0.23%
Shareholder Yield	3.96%
Earnings Yield	5.08%
FCF Yield	5.94%

Dividend Details

Stock Splits

The last stock split was on January 24, 2024. It was a forward split with a ratio of 2.

Last Split Date	Jan 24, 2024
Split Type	Forward
Split Ratio	2

Scores

Pfizer has an Altman Z-Score of 2.11 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.11
Piotroski F-Score	6